Calendar Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Real-time Estimate Cboe BZX 10:56:35 07/05/2024 pm IST 5-day change 1st Jan Change
4.045 USD -1.82% Intraday chart for Akoya Biosciences, Inc. +6.02% -17.01%

Chart calendar Akoya Biosciences, Inc.

529a.A9jsxTmphj2LYBIBdhXRY6RwfS-eUW7fx4k4BOWZ0RY.c62IgQrQ01_IVWBKDyeALekTBVznCTmN8bt-YNXo6FU2h6G_SuDNU9wyeQ~8e1300615f3ce90366e9b9cbe41f2290

Upcoming events on Akoya Biosciences, Inc.

13/05/2024 Q1 2024 Earnings Release After hours
14/05/2024 02:30 am Q1 2024 Earnings Call
04/06/2024 Annual General Meeting
05/08/2024 Q2 2024 Earnings Release (Projected)
04/11/2024 Q3 2024 Earnings Release (Projected)
10/03/2025 Q4 2024 Earnings Release (Projected)
20/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Akoya Biosciences, Inc.

05/03/2024 03:30 am Q4 2023 Earnings Call
05/03/2024 02:35 am Q4 2023 Earnings Release
13/02/2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
11/01/2024 05:15 am JPMorgan Healthcare Conference
07/01/2024 06:30 pm Q1 2023 Sales and Revenue Release
30/11/2023 10:00 pm Piper Sandler Healthcare Conference
17/11/2023 01:00 am Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum
15/11/2023 10:30 pm Stephens Investment Conference
09/11/2023 03:30 am Q3 2023 Earnings Call
09/11/2023 02:30 am Q3 2023 Earnings Release
04/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting - Poster Number 570
04/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting - Poster Number 90
04/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting - Poster Number 124
03/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting - Poster Number 105
03/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting - Poster Number 117
03/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting - Poster Number 97
03/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting - Poster Number 75
13/09/2023 07:40 pm Morgan Stanley Global Healthcare Conference
18/08/2023 03:30 am UBS Genomics 2.0 and MedTech Innovations Summit
09/08/2023 06:30 pm Canaccord Growth Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
42,4


54,9
54,7
0.37%
74,9
74,1
0.99%
96,6
96,3
0.37%

116

EBITDA
Million USD
Released
Forecast
Spread
0,00


-34,6
-29,0
-19.23%
-59,4
-55,6
-6.82%
-49,6
-50,6
1.9%

-26,5

EBIT
Million USD
Released
Forecast
Spread
0,00


-39,3
-33,0
-18.99%
-66,1
-62,9
-5.04%
-57,7
-60,2
4.14%

-36,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-43,1
-36,4
-18.5%
-70,5
-67,6
-4.31%
-63,3
-65,4
3.26%

-40,1

Net income
Million USD
Released
Forecast
Spread
-16,7


-44,4
-37,3
-18.95%
-70,6
-67,8
-4.2%
-63,3
-66,1
4.21%

-41,4

EPS
USD
Released
Forecast
Spread
-9,18


-1,65
-2,41
31.44%
-1,87
-1,81
-3.09%
-1,43
-1,48
3.08%

-0,84

Announcement Date26/03/2114/03/2206/03/2304/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
16,2
16,1
0.67%
16,9
14,9
13.13%
17,9
16,9
5.73%
18,9
17,7
6.76%
21,2
20,5
3.72%
21,4
20,3
5.36%
23,5
22,4
4.82%
25,2
24,5
2.75%
26,5
26,1
1.44%

24,3


27,5


30,2


33,7


30,0

EBITDA
Million USD
Released
Forecast
Spread
-15,4
-10,3
-50.3%
-14,0
-14,5
3.04%
-14,7
-12,3
-19.44%
-14,8
-13,0
-14.14%
-15,8
-13,2
-20.24%
-15,5
-14,9
-3.47%
-17,4
-13,4
-30.21%
-9,18
-11,5
19.86%
-7,57
-9,66
21.71%

-10,8


-7,33


-5,30


-3,60


-4,10

EBIT
Million USD
Released
Forecast
Spread
-16,8
-10,8
-55.85%
-15,6
-13,2
-17.54%
-16,3
-12,6
-29.94%
-16,7
-15,8
-5.49%
-17,6
-15,4
-14.44%
-17,4
-17,3
-0.85%
-19,2
-16,4
-17.33%
-11,6
-15,0
22.93%
-9,44
-12,2
22.73%

-13,1


-10,5


-7,63


-5,16


-8,25

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-17,8
-11,0
-61.73%
-16,4
-14,2
-15.6%
-17,4
-12,7
-36.56%
-17,9
-16,4
-8.62%
-18,9
-15,9
-18.69%
-18,8
-18,4
-1.94%
-20,8
-17,7
-17.66%
-12,9
-16,5
21.68%
-10,8
-13,2
18.23%

-14,1


-11,5


-8,45


-5,95


-9,63

Net income
Million USD
Released
Forecast
Spread
-17,7
-11,0
-60.66%
-16,4
-14,2
-15.76%
-17,5
-13,4
-30.32%
-17,9
-16,5
-8.03%
-18,9
-16,0
-17.99%
-18,8
-18,7
-0.45%
-20,8
-17,8
-16.93%
-12,9
-16,5
21.55%
-10,8
-13,8
21.65%

-14,3


-11,8


-8,90


-6,43


-9,85

EPS
USD
Released
Forecast
Spread
-0,47
-0,30
-58.43%
-0,44
-0,39
-13.55%
-0,47
-0,37
-26.34%
-0,47
-0,44
-6.82%
-0,50
-0,44
-13.31%
-0,49
-0,49
-0.75%
-0,51
-0,46
-10.99%
-0,26
-0,36
28.63%
-0,22
-0,28
21.02%

-0,29


-0,24


-0,18


-0,14


-0,19

Announcement Date14/03/2205/05/2208/08/2207/11/2206/03/2308/05/2307/08/2308/11/2304/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AKYA Stock
  4. Calendar Akoya Biosciences, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW